Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
09/2000
09/28/2000WO2000056358A2 Vaccine against streptococcus pneumoniae capsular polysaccharides
09/28/2000WO2000056357A2 Staphylococcus antigen and vaccine
09/28/2000WO2000056343A1 Use of fucosylated sialylated n-acetyl lactosamine carbohydrate structures for inhibition of bacterial adherence
09/28/2000WO2000056298A2 Treatment of lyme disease with polysulfated glycosaminoglycan formulations
09/28/2000WO2000056282A1 Particle based vaccine composition
09/28/2000WO2000056144A1 Human sperm surface antigen
09/28/2000WO2000042194A3 Mutant hepatitis b surface antigen and testing
09/28/2000WO2000041740A3 Particles for oral delivery of peptides and proteins
09/28/2000WO2000026394A9 Variants of humanized anti-carcinoma monoclonal antibody cc49
09/28/2000WO2000025807A9 Binding moieties for human parvovirus b19
09/28/2000WO2000023592A9 Minimal promoters and uses thereof
09/28/2000WO2000023114A3 Polymer conjugates of interferon beta- 1a and their uses
09/28/2000WO2000022142A3 Cell signaling polypeptides and nucleic acids
09/28/2000WO2000020576A3 Methods and compositions for inducing differentiation and apotosis in cells that overexpess the notch protein
09/28/2000WO2000020447A3 Polynucleotides coding for secreted polypeptides, some having similarity to syncollin or claudin or cytokine, their therapeutic uses
09/28/2000WO2000016808A3 Antibody directed enzyme prodrug therapy (edept) with glucoronidase
09/28/2000WO2000015793A3 Human gpcr proteins
09/28/2000WO2000013706A9 Methods for detecting, preventing, and treating renal disorders by modulating, regulating, and inhibiting connective tissue growth factor
09/28/2000DE19910102A1 Proteinkonjugate, Verfahren, Vektoren, Proteine und DNA zu deren Herstellung, deren Verwendung, sowie Arzneimittel und Impfstoffe mit einem Gehalt derselben Protein conjugates, methods, vectors, proteins, and DNA for their preparation, their use, as well as drugs and vaccines containing the same
09/28/2000CA2669512A1 Human antibodies that bind human il-12 and methods for producing
09/28/2000CA2368229A1 50 human secreted proteins
09/28/2000CA2367464A1 Materials and methods relating to modulation of p66 expression
09/28/2000CA2367025A1 Treatment of lfa-1 associated disorders with increasing doses of lfa-1 antagonist
09/28/2000CA2366908A1 Vaccine composition
09/28/2000CA2366869A1 Use of trehalose for stabilising a liquid vaccine
09/28/2000CA2366691A1 48 human secreted proteins
09/28/2000CA2366613A1 Particle based vaccine composition
09/28/2000CA2366552A1 Method for detecting superantigen activity in a biological sample
09/28/2000CA2366214A1 Dsp-2 dual-specificity map kinase phosphatase
09/28/2000CA2366152A1 Streptococcus pneumoniae vaccine
09/28/2000CA2366132A1 48 human secreted proteins
09/28/2000CA2365405A1 Human tumor necrosis factor receptor-like 2
09/28/2000CA2365296A1 Vaccine
09/28/2000CA2365255A1 Human tumor necrosis factor receptor tr9
09/28/2000CA2365238A1 48 human secreted proteins
09/28/2000CA2365223A1 46 human secreted proteins
09/28/2000CA2365121A1 Antibodies specific for cyp1b1
09/28/2000CA2365104A1 Anti-p53 antibodies
09/28/2000CA2361221A1 Novel protein which induces chondrocyte differentiation
09/27/2000EP1038962A1 Peptidoglycan biosynthetic gene murF from Streptococcus pneumoniae
09/27/2000EP1038958A1 HUMAN Nap1 PROTEIN
09/27/2000EP1038952A2 Processes for preparation of Marek's Disease Virus using continuous avian cell lines
09/27/2000EP1038019A1 NOVEL ribB
09/27/2000EP1038001A2 Constitutive expression of non-infectious hiv-like particles
09/27/2000EP1038000A1 Compounds and methods for the detection and prevention of (t. cruzi) infection
09/27/2000EP1037999A1 Porphorymonas gingivalis polypeptides and nucleotides
09/27/2000EP1037998A1 guaA POLYPEPTIDES
09/27/2000EP1037997A1 Lmb gene of streptococcus agalactiae
09/27/2000EP1037995A1 Human interferon-epsilon: a type 1 interferon
09/27/2000EP1037993A2 A new gene called oligophrenin 1, its expression product, and the diagnostic and therapeutic applications thereof
09/27/2000EP1037974A1 Hepatitis c virus ns5b truncated protein and methods thereof to identify antiviral compounds
09/27/2000EP1037967A2 Human phosphatases
09/27/2000EP1037926A1 TREATMENT WITH ANTI-ErbB2 ANTIBODIES
09/27/2000EP1037918A1 Method and composition to enhance the efficacy of a vaccine using chemokines
09/27/2000EP1037917A1 Recombinant nodavirus compositions and methods
09/27/2000EP1037916A2 Erythrovirus and its applications
09/27/2000EP1037912A1 DNA MOLECULES ENCODING VERTEBRATE NUCLEAR RECEPTOR PROTEIN, nNR4
09/27/2000EP1037911A1 Anti-pathogen system and methods of use thereof
09/27/2000EP1037909A2 Postweaning multisystemic wasting syndrome virus from pigs
09/27/2000EP1037901A1 Mammaglobin, a secreted mammary-specific breast cancer protein
09/27/2000EP1037665A1 Methods and compositions for inhibiting tumor cell growth
09/27/2000EP1037664A1 Vaccines containing attenuated bacteria
09/27/2000EP1037662A1 Method to enhance an immune response of nucleic acid vaccination
09/27/2000EP1037661A1 ribH
09/27/2000EP1037660A1 ribB
09/27/2000EP1037656A1 Lymphotactin as an adjuvant
09/27/2000EP1037655A2 Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof
09/27/2000EP1037654A1 ribA
09/27/2000EP1037650A1 Methods and compositions for the treatment and prevention of staphylococcus aureus infections
09/27/2000EP1037645A1 Processes of making north american ginseng fractions, products containing them, and use as immunomodulators
09/27/2000EP1037643A1 Cancer immunotherapy using allostimulated cells in a multiple sequential implantation strategy
09/27/2000EP1037603A1 Membrane virus host range mutations and their uses as vaccine substrates
09/27/2000EP1037530A1 ribG
09/27/2000EP0754055B1 Group a streptococcal polysaccharide immunogenic compositions and methods
09/27/2000EP0648260B1 Fusobacterium necrophorum leukotoxoid vaccine
09/27/2000CN1268176A Improved anti-IgE antibodies and method of improving polypeptides
09/27/2000CN1268175A Catalytic monoclonal antibodies with protease activity for the selective lysis of the protein component of plaques and aggregates related to pathological conditions
09/27/2000CN1268054A Combination therapy comprising amlodipine and a statin compound
09/27/2000CN1268052A Therapeutic combinations comprising amlodipin and atorvastatin
09/27/2000CN1267724A Growth chalone as one genetic engineering matter and its live carrier vaccine
09/27/2000CN1267549A Oral immune globulin preparation and its preparing process
09/27/2000CN1056879C 重组马立克氏病病毒 Recombinant Marek's Disease Virus
09/27/2000CN1056878C Recombinant herpesvirus of turkeys and live vector vaccines derived thereof
09/27/2000CN1056876C Cultivation method for preparing oral live typhoidvaccine
09/26/2000US6124432 Bringing dermonecrotic toxin-containing solution into contact with chromatographic gel sulfated by direct sulfation or a chromatographic gel to which a sulfated molecule is covalently bonded to thereby adsorb dermonecrotic toxin on gel, eluting
09/26/2000US6124310 Enediyne compounds
09/26/2000US6124270 Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug
09/26/2000US6124119 Nucleotide sequences coding enzymatic polypeptide; for the treatment and prevention of bacterial infection; bactericides
09/26/2000US6124117 Polysaccharide binding fusion proteins and conjugates
09/26/2000US6124105 Method for detecting the presence of a mycobacterium species and a kit and antibodies for use therein
09/26/2000US6124101 Diagnosis of thrombosis in a mammals; incubating a sample of fluid with an antibody that preferentially binds a cleaved activation peptide, counting antibody bound cleaved activation peptides, compare to control
09/26/2000US6124095 Human nucleotide pyrophosphohydrolase-2
09/26/2000US6123949 A vaccine which comprises an effective immunizing amount of the genetically engineered fowlpox virus designated s-fpv-043, useful for immunizing the animal against disease caused by fowlpox virus and newcastle disease virus
09/26/2000US6123948 Antigenic determinants of atleast two human papilloma virus proteins selected from l1, l2, e1, e2, e3, e4, e5, e6, e7, in amorphous reaggregated form which when in solution can pass through a sterillization filter used as immunogenic
09/26/2000US6123942 Bacterial hemoglobin receptor gene
09/26/2000US6123939 Anti-neoplastic drugs in cancer therapy
09/26/2000CA2103460C Causative agent of the mystery swine disease, vaccine compositions and diagnostic kits
09/26/2000CA1341102C Tetra-aza macrocycles and metal complexes thereof
09/26/2000CA1341100C Determined dna sequences derived from a papilloma virus genome, their uses for in vitro diagnostic purposes and the production of antigenic compositions
09/21/2000WO2000055633A2 Methods of screening for colorectal cancer modulators
1 ... 1456 1457 1458 1459 1460 1461 1462 1463 1464 1465 1466 1467 1468 1469 1470 1471 1472 1473 1474 1475 1476 ... 1823